Serum lipase activity in chronic renal failure

Area of Science:

• Nephrology
• Biochemistry

Background:

• Chronic renal failure (CRF) affects kidney function.
• Hyperlipasemia is elevated serum lipase activity.
• The relationship between CRF and hyperlipasemia requires further investigation.

Purpose of the Study:

• To investigate the prevalence and severity of hyperlipasemia in patients with chronic renal failure.
• To explore the correlation between the degree of renal function decline and serum lipase activity.
• To compare hyperlipasemia frequency in different types of chronic kidney disease.

Main Methods:

• Serum lipase activity was measured in 110 patients with CRF.
• Glomerular filtration rate (GFR) was assessed to quantify renal function.
• Patients with chronic glomerulonephritis and chronic pyelonephritis were compared.
• Effects of hemodialysis on lipase activity were evaluated.
• Experimental CRF was induced in rats to validate findings.

Main Results:

• 46.4% of CRF patients exhibited hyperlipasemia (serum lipase > 200 IU/L).
• Reduced renal function correlated positively with hyperlipasemia frequency and severity.
• At GFR < 20 ml/min, hyperlipasemia was 75% in chronic glomerulonephritis vs. 46.8% in chronic pyelonephritis.
• Hemodialysis did not influence hyperlipasemia.
• Elevated serum lipase was observed in experimental rat models of CRF.

Conclusions:

• Hyperlipasemia is common in chronic renal failure.
• The severity of kidney dysfunction directly impacts serum lipase levels.
• Chronic glomerulonephritis presents a higher risk for hyperlipasemia compared to chronic pyelonephritis.